Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tropisetron for systemic inflammatory response after off-pump coronary artery bypass grafting
ChiCTR1800016927Phase 4Recruiting
- Sponsor
- Department of Anesthesiology, Beijing Chao-Yang Hospital
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tropisetron in Systemic Inflammatory Response Syndrome (SIRS) (2 arms), sponsored by Department of Anesthesiology, Beijing Chao-Yang Hospital. Primary endpoints: Serum interleukin-8, Serum interleukin-6 and 1 more. Started May 2018; status: recruiting.
02
Drugs
tropisetron
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on ChiCTR1800016927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016927.